SBC Medical Group Holdings Incorporated (SBC)
NASDAQ: SBC · Real-Time Price · USD
5.09
+0.02 (0.39%)
At close: Oct 2, 2026, 4:00 PM EDT
4.966
-0.120 (-2.44%)
After-hours: Oct 2, 2026, 4:27 PM EDT
SBC Revenue
SBC Medical Group Holdings had revenue of $49.19M in the quarter ending June 30, 2026, with 13.44% growth. This brings the company's revenue in the last twelve months to $175.17M, down -6.92% year-over-year. In the year 2025, SBC Medical Group Holdings had annual revenue of $173.61M, down -15.48%.
Revenue (ttm)
$175.17M
Revenue Growth
-6.92%
P/S Ratio
2.99
Revenue / Employee
$202,976
Employees
863
Market Cap
523.49M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 173.61M | -31.81M | -15.48% |
| Dec 31, 2024 | 205.42M | 11.87M | 6.13% |
| Dec 31, 2023 | 193.54M | 19.38M | 11.13% |
| Dec 31, 2022 | 174.16M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
SBC News
- 3 days ago - SBC Medical Group Holdings Transcript: Lytham Partners Fall 2026 Investor Conference - Transcripts
- 7 days ago - SBC Medical to Participate in Several Upcoming Investor Conferences in October 2026 - GlobeNewsWire
- 14 days ago - SBC Medical Group Holdings Transcript: Small-Cap Virtual Conference - Transcripts
- 22 days ago - SBC Medical to Attend the ArcStone-Kingswood Growth Summit 2026 in Toronto - Newsfile Corp
- 4 weeks ago - SBC Medical to Participate in Several Upcoming Investor Conferences in September 2026 - Business Wire
- 5 weeks ago - Emerging Growth Research Issues Updated Press Release Announcing Company-Sponsored Research on SBC Medical Group Holdings Incorporated - Accesswire
- 5 weeks ago - SBC Medical Group Holdings Transcript: Q3 Investor Summit Group Virtual Conference 2026 - Transcripts
- 5 weeks ago - Emerging Growth Research Releases Q2:26 Quarterly Update on SBC Medical Group; Reiterates Buy Rating and Increases Price Target to $11.00 - Accesswire